Common Contracts
16 similar Employment Agreement contracts by CRISPR Therapeutics AG, FibroBiologics Inc.
EMPLOYMENT AGREEMENTEmployment Agreement • August 5th, 2024 • CRISPR Therapeutics AG • Biological products, (no disgnostic substances) • Massachusetts
This Employment Agreement (“Agreement”) is made as of the 28th day of May, 2024 between CRISPR Therapeutics, Inc., a Delaware corporation (the “Company”), and Naimish Patel (the “Executive” and, together with the Company, the “Parties” or each individually, a “Party”).
EMPLOYMENT AGREEMENTEmployment Agreement • May 23rd, 2024 • CRISPR Therapeutics AG • Biological products, (no disgnostic substances) • Massachusetts
This Employment Agreement (“Agreement”) is made as of the 23rd day of May, 2024 between CRISPR Therapeutics, Inc., a Delaware corporation (the “Company”), and Julianne Bruno (the “Executive” and, together with the Company, the “Parties” or each individually, a “Party”).
EMPLOYMENT AGREEMENTEmployment Agreement • December 4th, 2023 • FibroBiologics Inc. • Pharmaceutical preparations • Massachusetts
This Employment Agreement (“Agreement”) is made this December 1, 2023 (the “Effective Date”) between FibroBiologics, Inc., a Delaware corporation (the “Company”) and Peter O’Heeron (the “Executive” and, together with the Company, the “Parties” or each individually, a “Party”).
EMPLOYMENT AGREEMENTEmployment Agreement • March 14th, 2023 • CRISPR Therapeutics AG • Biological products, (no disgnostic substances) • Massachusetts
This Employment Agreement (“Agreement”) is made as of the 14th day of March, 2023 between CRISPR Therapeutics, Inc., a Delaware corporation (the “Company”), and Raju Prasad (the “Executive” and, together with the Company, the “Parties” or each individually, a “Party”).
EMPLOYMENT AGREEMENTEmployment Agreement • August 8th, 2022 • CRISPR Therapeutics AG • Biological products, (no disgnostic substances) • Massachusetts
This Employment Agreement (“Agreement”) is made as of the 23rd day of May, 2022 between CRISPR Therapeutics, Inc., a Delaware corporation (the “Company”), and Phuong Khanh Morrow (the “Executive” and, together with the Company, the “Parties” or each individually, a “Party”).
EMPLOYMENT AGREEMENTEmployment Agreement • October 14th, 2021 • CRISPR Therapeutics AG • Biological products, (no disgnostic substances) • Massachusetts
This Employment Agreement (“Agreement”) is made as of the 14th day of October, 2021 between CRISPR Therapeutics, Inc., a Delaware corporation (the “Company”), and Brendan Smith (the “Executive” and, together with the Company, the “Parties” or each individually, a “Party”).
EX-10.1 2 d406376dex101.htm EX-10.1 SECOND AMENDED AND RESTATED EMPLOYMENT AGREEMENTEmployment Agreement • May 5th, 2020 • Massachusetts
This Second Amended and Restated Employment Agreement (“Agreement”) is made this 2nd day of October 2017 (the “Effective Date”) between CRISPR Therapeutics, Inc., a Delaware corporation (the “Company”) and a wholly-owned subsidiary of CRISPR Therapeutics AG (“Parent”), and Samarth Kulkarni (the “Executive” and, together with the Company, the “Parties” or each individually, a “Party”).
EMPLOYMENT AGREEMENTEmployment Agreement • February 25th, 2019 • CRISPR Therapeutics AG • Biological products, (no disgnostic substances) • Massachusetts
This Employment Agreement (“Agreement”) is made as of the 2nd day of January, 2019 between CRISPR Therapeutics, Inc., a Delaware corporation (the “Company”), and Lawrence Klein (the “Executive” and, together with the Company, the “Parties” or each individually, a “Party”).
EMPLOYMENT AGREEMENTEmployment Agreement • March 8th, 2018 • CRISPR Therapeutics AG • Biological products, (no disgnostic substances) • Massachusetts
This Employment Agreement (“Agreement”) is made as of the 13th day of November, 2017, between CRISPR Therapeutics, Inc., a Delaware corporation (the “Company”‘), and Michael Tomsicek (the “Executive” and, together with the Company, the “Parties” or each individually, a “Party”).
EMPLOYMENT AGREEMENTEmployment Agreement • March 8th, 2018 • CRISPR Therapeutics AG • Biological products, (no disgnostic substances) • Massachusetts
This Employment Agreement (“Agreement”) is made as of the 31st day of May, 2017, between CRISPR Therapeutics, Inc., a Delaware corporation (the “Company”), and James R. Kasinger (the “Executive” and, together with the Company, the “Parties” or each individually, a “Party”).
EMPLOYMENT AGREEMENTEmployment Agreement • March 8th, 2018 • CRISPR Therapeutics AG • Biological products, (no disgnostic substances) • Massachusetts
This Employment Agreement (“Agreement”) is made as of the 1st day of August, 2017, between CRISPR Therapeutics, Inc., a Delaware corporation (the “Company”), and Tony W. Ho (the “Executive” and, together with the Company, the “Parties” or each individually, a “Party”),
SECOND AMENDED AND RESTATED EMPLOYMENT AGREEMENTEmployment Agreement • October 2nd, 2017 • CRISPR Therapeutics AG • Biological products, (no disgnostic substances) • Massachusetts
This Second Amended and Restated Employment Agreement (“Agreement”) is made this 2nd day of October 2017 (the “Effective Date”) between CRISPR Therapeutics, Inc., a Delaware corporation (the “Company”) and a wholly-owned subsidiary of CRISPR Therapeutics AG (“Parent”), and Samarth Kulkarni (the “Executive” and, together with the Company, the “Parties” or each individually, a “Party”).
AMENDED AND RESTATED EMPLOYMENT AGREEMENTEmployment Agreement • May 4th, 2017 • CRISPR Therapeutics AG • Biological products, (no disgnostic substances) • Massachusetts
This Amended and Restated Employment Agreement (“Agreement”) is made this 3rd day of May 2017 (the “Effective Date”) between CRISPR Therapeutics, Inc., a Delaware corporation (the “Company”), and Samarth Kulkarni, (the “Executive” and, together with the Company, the “Parties” or each individually, a “Party”).
AMENDED AND RESTATED EMPLOYMENT AGREEMENTEmployment Agreement • October 7th, 2016 • CRISPR Therapeutics AG • Biological products, (no disgnostic substances) • Massachusetts
This Amended and Restated Employment Agreement (“Agreement”) is made this 6th day of October, 2016, between CRISPR Therapeutics, Inc., a Delaware corporation (the “Company”), and Sven Ante Lundberg, MD, an individual with a principal residence at [—] (the “Executive” and, together with the Company, the “Parties” or each individually, a “Party”).
EMPLOYMENT AGREEMENTEmployment Agreement • October 7th, 2016 • CRISPR Therapeutics AG • Biological products, (no disgnostic substances) • Massachusetts
This Employment Agreement (“Agreement”) is made this 6th day of October, 2016, between CRISPR Therapeutics, Inc., a Delaware corporation (the “Company”), and Samarth Kulkarni, (the “Executive” and, together with the Company, the “Parties” or each individually, a “Party”).
AMENDED AND RESTATED EMPLOYMENT AGREEMENTEmployment Agreement • October 7th, 2016 • CRISPR Therapeutics AG • Biological products, (no disgnostic substances) • Massachusetts
This Amended and Restated Employment Agreement (“Agreement”) is made this 6th day of October, 2016, between CRISPR Therapeutics, Inc., a Delaware corporation (the “Company”), and Marc Becker (the “Executive” and, together with the Company, the “Parties” or each individually, a “Party”).
